University of Florida Innovators Honored at 4th Annual Standing InnOvation Event
On a sunny and fresh fall afternoon, UF Innovate | Tech Licensing hosted its annual event to recognize top innovations stemming out of the University of Florida. More than 150 innovators and entrepreneurs attended the in-person event, and around 40 joined the livestream to celebrate their achievements in fiscal year 2021.
University of Florida Health Ophthalmology Researcher Awarded Prestigious Prize for Pioneering Work
University of Florida Health ophthalmology researcher William W. Hauswirth, Ph.D., whose long and distinguished career includes developing and testing treatments for multiple forms of genetic blindness, is among the scientists being recognized for their pioneering work to eradicate vision loss.
Roche Makes $4.8 Billion Bid for Spark Therapeutics and Its Gene Therapy Programs
Research by UF’s Dr. William Hauswirth is behind the gene therapy that resulted in Spark Therapeutics’ Luxturna, an FDA-approved gene therapy for... Read More
Ophthotech Expands Gene Therapy Pipeline in Orphan Retinal Diseases with Exclusive Option for Novel Product Candidates to Treat Best Vitelliform Macular Dystrophy (Ophthotech)
Ophthotech Corporation announced that it has entered into an exclusive option agreement with the University of Pennsylvania (Penn) and the University of... Read More
UF Health Researcher, Collaborators Share $1.2 Million International Award for Vision Treatment (UF Health)
University of Florida Health ophthalmology researcher William Hauswirth, Ph.D. and his collaborators are sharing in a $1.2 million international award for developing... Read More
Researchers Find Potential New Gene Therapy for Blinding Disease (National Institutes of Health)
UF researchers Dr. Alfred Lewin and Dr. William Hauswirth, in collaboration with UPenn researchers, reported a gene therapy that may slow or... Read More
U of Florida and Penn Ink Licensing Deal for Gene Therapy to Treat Retinal Disease (Tech Transfer eNews Blog)
Biotech company Ophthotech Corporation has entered into an exclusive global license agreement with the University of Florida Research Foundation (UFRF) and the... Read More
